ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 275,82
-0,04%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Phoenix Biotech Aquisition Corporation (PBAX)

  7. Phoenix Biotech Aquisition Corporation (PBAX) Actualités

PBAX

Phoenix Biotech Aquisition (PBAX)

Phoenix Biotech Aquisition Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PBAX
DateHeureSourceTitreSymboleSociété
14/02/202422h48Business WirePhoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business CombinationNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
07/06/202312h05Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/06/202315h27Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/06/202314h00Business WireCERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell TherapeuticsNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
12/05/202322h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
24/03/202311h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
14/02/202321h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
14/02/202312h11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
20/12/202222h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
21/11/202214h39Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
04/11/202221h07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
22/11/202122h15GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021NASDAQ:PBAXPhoenix Biotech Aquisition Corporation
08/10/202122h00GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment OptionNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
05/10/202123h19GlobeNewswire Inc.Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public OfferingNASDAQ:PBAXPhoenix Biotech Aquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:PBAX

Dernières Valeurs Consultées

USOTC
NBCLF
Nitto Boseki (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés